PMI

Picard Medical, Inc. (PMI) is a healthcare company operating in the medical devices industry. With a market capitalization of $123.08M, PMI has a significant presence in its sector, generating revenue of $4.77M and employing 75 individuals. Financially, PMI exhibits considerable strain. The company's net income (TTM) stands at -$32,220,000, with an EBITDA loss of -$13,661,000 and free cash flow of -$10,742,875. Cash reserves amount to $2.81M, while debt totals $616,000. This results in a debt-to-equity ratio of 7.73. Margins are also under pressure, with gross margin at -10.0%, operating margin at -293.8%, and profit margin at 0.0%. Return on assets is notably negative, at -67.3%. Valuation metrics indicate that PMI's price-to-book ratio stands at 15.46, while its price-to-sales ratio is higher at 25.82. The company's EV/EBITDA ratio is significantly negative, at -9.66. Revenue growth over the past year has been substantial, reaching 34.7%. However, earnings growth is not available for comparison. With a current dividend yield of N/A and payout ratio of 0.0%, PMI does not currently offer dividends to shareholders.